Two Sigma Securities’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,000
Closed -$531K 1874
2020
Q1
$531K Buy
+3,000
New +$565K 0.01% 601
2019
Q3
Sell
-33,100
Closed -$5.54M 2615
2019
Q2
$5.54M Buy
+33,100
New +$4.58M 0.06% 219
2019
Q1
Sell
-63,700
Closed -$8.51M 2645
2018
Q4
$8.51M Sell
63,700
-33,800
-35% -$5.54M 0.1% 103
2018
Q3
$18.6M Buy
97,500
+53,300
+121% +$9.79M 0.12% 110
2018
Q2
$7.37M Sell
44,200
-69,800
-61% -$11.2M 0.04% 371
2018
Q1
$19.2M Buy
114,000
+110,100
+2,823% +$18.5M 0.11% 162
2017
Q4
$638K Buy
+3,900
New +$700K 0.02% 585

Other funds holding AGN

Two Sigma Securities's AGN Position: Q1 2020 in Review

Two Sigma Securities sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 5,492 shares — an estimated $1.03M sold.

Two Sigma Securities first reported a position in AGN in Q3 2015 and held it in 17 quarters. The position peaked at $4.79M in Q2 2019. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Two Sigma Securities reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Two Sigma Securities sold 5,492 Allergan plc shares in Q1 2020, an estimated $1.03M.
  • Two Sigma Securities first reported a position in Allergan plc in Q3 2015 and held it in 17 quarters.
  • Two Sigma Securities's Allergan plc position peaked at $4.79M in Q2 2019.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Two Sigma Securities's 13F filing for Q1 2020, filed 15 May 2020.